Marie‐Olivia Chandesris

Author

Also Known As

M O Chandesris, M-O Chandesris, M. O. Chandesris, M.-O Chandesris, M.-O. Chandesris, M.O. Chandesris, M.‐O. Chandesris, MO. Chandesris, Maria Olivia Chandesris, Marie Olivia Chandesris

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Hôpital Necker-Enfants Malades Université Paris Cité Assistance Publique – Hôpitaux de Paris Inserm Centre National de la Recherche Scientifique

About

Marie‐Olivia Chandesris is an author at Hôpital Necker-Enfants Malades specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	702
2	Allergy	4	4	185
3	Engineering	1	1	58
4	Anatomy	1	1	15
5	Gastroenterology	1	1	81

Marie‐Olivia Chandesris

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Mutations in <i>STAT3</i> and <i>IL12RB1</i> impair the development of human IL-17–producing T cells Ludovic de Beaucoudrey, Anne Puel, Orchidée Filipe‐Santos, The Journal of Experimental Medicine	2008	428
Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome Marie‐Olivia Chandesris, Isabelle Melki, Angels Natividad, Medicine	2012	323
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity Vivien Béziat, Juan Li, Jian‐Xin Lin, Science Immunology	2018	186
Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study Georgia Malamut, Marie‐Olivia Chandesris, Virginie Verkarre, Digestive and Liver Disease	2013	160
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis Stéphane Barète, Olivier Lortholary, Gandhi Damaj, Blood	2015	143
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study Olivier Lortholary, Marie‐Olivia Chandesris, C. Bulaï Livideanu, The Lancet MedicineMast Cell DisorderAllergyScleroderma	2017	119
In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells Erinn Soucié, Katia Hanssens, Thomas Mercher, Blood	2012	96
Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis Sophie Georgin‐Lavialle, Daniela Silva Moura, Alexandre Salvador, Molecular Psychiatry InflammationPsychoneuroimmunologyStress HormonePsychiatryMast Cell Disorder	2016	82
Gastrointestinal manifestations in mastocytosis: A study of 83 patients Harry Sokol, Sophie Georgin‐Lavialle, Danielle Canioni, Journal of Allergy and Clinical Immunology Gastrointestinal ManifestationsMast Cell DisorderHistopathologyGastroenterologyPathology	2013	81
ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases Gandhi Damaj, Magalie Joris, Marie‐Olivia Chandesris, PLoS ONE Hematological MalignancyAutoimmune DiseaseSclerodermaMedicineSystemic Mastocytosis	2014	77

Page 1